|
Market Cap (25-Jun) $27,342,400 (1,032nd) |
Close (30-Jun) $0.008 |
Volume (30-Jun) 285,280 |
Shortsold (12-Dec) 6,497 (0.00%) (681st) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.09 |
EX1 released this announcement to the ASX on 29 March 2023, 8:22. The announcement is not marked as price sensitive, and is 18 page(s) in length and 479.86kb in size.
You can view all announcements from EX1 and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from EX1 | |
|---|---|
| Initial Director's Interest Notice - MD | 22 June 2023, 11:52 |
| Change of Director's Interest Notice - CB | 22 June 2023, 11:51 |
| Final Director's Interest Notice - JW | 22 June 2023, 11:50 |
| Notice of General Meeting/Proxy Form | 29 March 2023, 8:22 |
| Proposed issue of securities - EX1 | 23 March 2023, 8:53 |
| Proposed issue of securities - EX1 | 23 March 2023, 8:50 |
| Exopharm Limited announces Non-Renounceable Pro Rata Rights | 23 March 2023, 8:37 |
You must be logged in to post a reply.
Exopharm 